You joined us for an engaging discussion as we provided updates and explored co-creation opportunities around key topics. Your insights and participation were vital in shaping our collaborative approach! We engaged in an open exchange on this balancing act, building on the PH Strategy guardrails discussed previously in Q1. Dynamic shared ownership and co-creation were crucial to our approach, and we introduced the IT PH Squad and its role as a cornerstone of our co-creation efforts.

🎉 Congratulations! If you've got this POAP, you’re officially in the exclusive club of folks who are ready to break free from the Bayer CloudTech UserGroup email chain! 🥳 Time to wave goodbye to those inbox notifications! ✌️💌

Head of Business Disruption, Bayer Pharmaceuticals. I love Stranger Things, MoreScience4Berlin, STEM4Health, Hackathons, Biotech, Digital Health, Startups, Web3, Networking For Health, Science, Technology, Pharma, Medicine, 23andMe, Exobiology, Space, Science Fiction, Germany, Cuba. #Byron #ByronBar #POAP #HackAProcess #HackAPill #ItIsNeverTooLate https://www.linkedin.com/in/yeysus/ https://twitter.com/yeysus yeysus.eth/.tez/.near POAP collections: https://collections.poap.xyz/en-US?creator=0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC Bayer Berlin: https://collections.poap.xyz/bayer-berlin/173 The future doesn’t belong to the fainthearted. It belongs to the Brave. - Ronald Reagan's Address to the Nation about the Explosion of the Space Shuttle Challenger, January 28th, 1986. Art by ChatGPT. It does not look at all like me, but this is what she suggested based on an, actually with correct results, search she did in internet.

Thank you for attending today's DT & IT Pharma Townhall! In today's meeting, we delved deeper into the successful launch of the Pharma Control Tower (go/PHCT), which serves as a central entry point for all your needs related to financial, operational stability, and governance for your applications, portfolios, and functions. Additionally, we shared some updates on the rollout of MyGenAssist at Pharma, highlighting our crucial role as key ambassadors. This past year has underscored the accelerated pace of innovation, with GenAI standing out as a prime example of the agility needed to proactively evolve our skill sets. Furthermore, we collectively reviewed our key priorities for 2024 and provided updates on our DSO learning journey. In summary: ///// PH Control Tower ///// Business priorities per department ///// MyGenAssist roll-out PH ///// DSO Champions update Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

Another DSO Open MIC session is in the books! Whether you have attended the morning or afternoon session, without a doubt you have contributed significantly to the success of today's event. These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded. Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

Thank you for joining our first DSO Open Mic session in 2024!! These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded.